Overview

Detailed Summary

N G Industries Limited operates primarily in the healthcare sector, providing a range of medical services through divisions like N. G. Medicare & Calcutta Hope Infertility Clinic, N. G. Nursing Home, and N. G. Pharmacy.
Founded in 1994, the company pioneered private healthcare in Kolkata, eventually establishing a strong brand within the city and suburbs, particularly recognized in South Kolkata.
N G Industries offers comprehensive healthcare solutions encompassing diagnostics, inpatient and outpatient services, and pharmacies, supported by advanced technology and experienced professionals.
N G Medicare, a subsidiary, is a leading diagnostic center in South Kolkata offering specialized medical services and has been NABL accredited, highlighting its commitment to quality and precision.
The company emphasizes accessibility and affordability, ensuring the use of modern technology and efficient service delivery at reasonable costs, thus appealing to a broad patient base.

Sector: Healthcare
Industry: Hospitals / Medical Services
Market Cap: 45 Cr
Volatility: Low Risk
P/E Ratio: -32.7
Industry P/E: 60.4
PEG Ratio: —
P/B Ratio: 1.2
52W High: 186.90
52W Low: 120.05

Sales CAGR

1Y: -9.73%
3Y: 12.42%
5Y: -0.90%
10Y: 1.42%

Profit CAGR

1Y: -39.54%
3Y: 101.66%
5Y: 34.95%
10Y: 15.02%

ROE

TTM: 12.51%
3Y: 18.08%
5Y: 16.02%
10Y: 14.13%

ROCE

TTM: 14.95%
3Y: 21.38%
5Y: 19.39%
10Y: 18.39%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
SANGANI	44.45	61 Cr	23.64	1.70	0.00	5.09	6.48	3.76
SHANMUGA	39.00	53 Cr	9.68	1.34	0.00	9.17	11.55	7.01
NGIND	135.20	45 Cr	-32.74	1.16	0.00	12.51	14.95	-3.23
AATMAJ	19.75	45 Cr	70.54	0.89	0.00	1.67	4.07	1.30
SAFECURE	34.00	34 Cr	3.96	0.66	0.00	29.21	23.90	12.72
CMMHOSP	40.98	31 Cr	-37.60	0.00	0.00	35.31	-0.76	-3.69
SHARMEH	93.00	31 Cr	25.83	2.49	0.00	9.84	10.99	3.78

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	4.33	3.95	4.07	3.70	4.38	4.00	4.47	3.70	4.05	4.29
Expenses	3.80	3.54	3.55	3.31	3.93	3.59	3.92	3.36	3.72	3.79
Operating Profit	0.53	0.41	0.52	0.39	0.45	0.41	0.55	0.34	0.33	0.50
OPM %	12.24	10.38	12.78	10.54	10.27	10.25	12.30	9.19	8.15	11.66
Other Income	0.35	0.26	1.87	0.32	3.20	7.67	-3.18	0.11	0.43	0.27
Interest	0.00	0.00	0.00	0.00	0.01	0.01	0.02	0.02	0.01	0.02
Depreciation	0.18	0.18	0.13	0.14	0.15	0.16	0.17	0.15	0.15	0.15
Profit Before Tax	0.70	0.48	2.26	0.57	3.49	7.91	-2.82	0.27	0.59	0.59
Tax %	8.57	12.50	14.16	12.28	14.90	15.17	13.83	29.63	27.12	28.81
Net Profit	0.64	0.43	1.94	0.50	2.97	6.71	-2.43	0.19	0.43	0.42
EPS in Rs	1.91	1.27	5.79	1.48	8.85	20.03	-7.26	0.58	1.28	1.27

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	17	17	17	18	19	12	18	19	17	17
Expenses	14	14	15	15	16	11	16	17	15	15
Operating Profit	3.07	2.82	2.61	2.26	2.47	1.20	2.29	1.81	1.96	1.75
OPM %	18.15	16.31	15.03	12.80	13.33	10.13	12.41	9.69	11.61	10.57
Other Income	-0.07	-0.02	0.13	0.14	0.20	0.14	1.63	8.37	4.51	7.80
Interest	0.01	0.01	0.01	0.10	0.09	0.02	0.02	0.01	0.02	0.06
Depreciation	0.58	0.57	0.60	0.57	0.56	0.49	0.58	0.52	0.60	0.63
Profit Before Tax	2.42	2.22	2.14	1.73	2.03	0.83	3.32	9.65	5.85	8.85
Tax %	36.62	36.10	34.21	34.97	27.67	26.28	21.38	13.82	14.01	15.93
Net Profit	1.53	1.42	1.41	1.12	1.47	0.61	2.61	8.32	5.03	7.44
EPS in Rs	4.57	4.24	4.20	3.35	4.38	1.83	7.78	164.82	15.02	-4.13
Dividend Payout %	76.59	82.55	83.33	104.17	0.00	0.00	44.93	14.10	23.30	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	3.35	3.35	3.35	3.35	3.35	3.35	3.35	3.35	3.35	3.35
Reserves	11	11	8.97	8.50	7.62	5.99	12	21	25	33
Borrowings	1.07	1.17	1.91	1.48	1.25	3.02	0.27	0.51	0.59	1.18
Other Liabilities	1.56	1.58	0.16	0.26	1.09	1.55	1.77	2.73	1.93	2.60
Total Liabilities	17	17	14	14	13	14	17	27	31	40
Fixed Assets	5.09	4.87	4.90	4.96	5.16	5.26	5.35	5.56	5.19	5.62
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	8.40	8.89	4.30	4.24	3.37	3.84	8.16	16	22	29
Other Assets	3.48	3.45	5.18	4.40	4.79	4.82	3.54	5.44	3.25	5.35
Total Assets	17	17	14	14	13	14	17	27	31	40

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity	1.77	2.01	1.85	2.43	3.82	2.85	1.35	-1.73	3.16	-1.02
Cash from Investing Activity	-0.62	-0.92	-0.89	-1.50	-1.09	-3.41	2.00	1.26	-1.72	2.25
Cash from Financing Activity	-2.16	-1.30	-0.68	-1.84	-1.75	0.27	-2.78	0.22	-1.11	-0.60
Net Cash Flow	-1.01	-0.21	0.28	-0.91	0.99	-0.29	0.57	-0.25	0.33	0.63

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	74.50%	74.50%	74.50%	74.50%	74.50%	74.50%	74.50%	74.50%	74.50%	74.50%	74.50%	74.50%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	25.50%	25.50%	25.50%	25.50%	25.50%	25.50%	25.50%	25.50%	25.50%	25.50%	25.50%	25.50%
Total Shareholders	1,683	1,748	1,931	2,045	2,088	2,111	2,199	2,195	2,201	2,188	2,250	2,220

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.